Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Salix Pharmaceuticals, Ltd. Stockholders Encouraged to Contact Securities Law Firm about Takeover | ||
| By: PR Newswire Association LLC. - 27 Feb 2015 | Back to overview list |
|
NEW YORK, Feb. 27, 2015 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating the board of Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) in connection with a buyout for only $158.00 per share. Concerned SLXP investors are encouraged to contact attorney Hamilton Lindley by clicking here. The investigation focuses upon the shareholder value of the transaction. Under terms of the proposed agreement, Salix shareholders would receive only $158.00 per share in cash. At least one analyst has set a target price of $185.00. The firm's potential shareholder lawsuit will seek to obtain the highest price reasonably available and that all important information about the deal is disclosed. Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. SLXP stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@dunnamlaw.com with questions, toll free at (844) 702-2990 or visit http://www.dunnamlaw.com/SLXP. Dunnam & Dunnam also practices personal injury law including Waco car accidents and Waco truck accidents.
SOURCE Dunnam & Dunnam 
|
||
|
||
| Copyright 2015 PR Newswire Association LLC. | Back to overview list | |